United States· US:59726-203_c180ed31-17af-48cf-a484-dc1e96911704

Allergy Relief

A fluticasone product containing fluticasone propionate, registered in United States by P & L Development, LLC. The same ATC class is registered in 14 of our 19 countries.

ATC R01AD08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAllergy ReliefATCR01AD08REGISTER NO.US:59726-203_c180ed31…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Fluticasone is registered in 14 of 19 countries.

Countries holding a registration under ATC R01AD08 (fluticasone), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Fluticasone · ATC R01AD08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FLUTICASONE PROPIONATE
Manufacturer
P & L Development, LLC
Country
United States (US)
ATC code
R01AD08
ATC class
Fluticasone
Defined daily dose
0.2 mg, N
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    5972620338
    1 BOTTLE, SPRAY in 1 CARTON (59726-203-38) / 72 SPRAY, METERED in 1 BOTTLE, SPRAY
  • ndc11
    5972620354
    1 BOTTLE, SPRAY in 1 CARTON (59726-203-54) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
  • ndc11
    59726-203-38
  • ndc11
    59726-203-54

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for fluticasone.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluticasone · interactions on record

55 records

  • 29 severe
  • 25 moderate
  • 1 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • TroleandomycinJ01FA08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Italy · Aktanos, Deflut
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2fae0ed-2f00-49b4-8b28-7770484630bf
GET /v1/drugs/b2fae0ed-2f00-49b4-8b28-7770484630bf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "NASAL",
  "source": "ndc",
  "strength": "50",
  "substance": "FLUTICASONE PROPIONATE",
  "productndc": "59726-203",
  "dosage_form": "SPRAY, METERED",
  "dea_schedule": null,
  "strength_unit": "ug/1",
  "application_number": "ANDA208150",
  "marketing_category": "ANDA"
}

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.